Health Union and DTC Perspectives Announce Executive Rare Disease Marketing Summit

Inaugural gathering on November 5, 2026, marks the launch of a lasting partnership between Health Union and DTC Perspectives to unite biopharma marketing leaders, elevate rare disease strategy, and address critical commercial, technical, and patient engagement shifts.

PHILADELPHIA, Sept. 22, 2026 /PRNewswire/ -- Health Union, the leader in online health communities, and DTC Perspectives, the premier conference and publishing company for consumer health marketers, today announced their inaugural joint venture: The Rare Marketing Summit: Redefining the Commercial Model for Rare Disease. 

A Landmark Partnership to Advance Rare Disease Marketing and Redefine Precision Commercial Strategies

This inaugural gathering marks the launch of a lasting strategic partnership between Health Union and DTC Perspectives. Designed as a dedicated platform for rare disease and niche oncology marketers, the collaboration brings together Health Union's deep patient and HCP engagement capabilities with DTC Perspectives' executive marketing network to establish a continuous forum for promoting innovation, peer collaboration, and commercial excellence, specific to the unique needs of these therapeutic areas. 

The exclusive, invitation-only summit will take place on Thursday, November 5, 2026, from 10:00 AM to 4:00 PM at The Westin Copley Place in Boston, MA with a cocktail reception to follow.

Fostering Innovation & Collaboration Among Rare Marketers

As medicine becomes increasingly specialized, the rare disease and niche oncology pipelines have emerged as the primary growth engine for the biopharma industry. However, traditional commercial playbooks fall short in hyper-targeted markets. By uniting their shared strengths, Health Union and DTC Perspectives are uniquely positioned to help biopharma marketers navigate these high-stakes challenges - from identifying ultra-small patient populations and activating generalist physicians to building high-touch caregiver experiences and collaborating with advocacy ecosystems.

Designed specifically for senior-level biopharma marketing leaders, this collaborative summit skips broad, surface-level presentations to focus on actionable, real-world strategies across six key topics:

• Diagnostic Acceleration: Commercial and technical strategies to shorten the diagnostic journey.
• Regulatory Compliance: Evolving FDA risk-disclosure standards across targeted marketing channels.
• DTC & Data Strategy: AI targeting, CTV channel expansion, and micro-audience analytics to activate precision audiences.
• Patient & Caregiver Experience: The role of high-touch, personalized journeys, community activation, and adherence support.
• Re-Engineered HCP Strategy: Generalist symptom recognition and sales force white-space coverage.
• Advocacy & Ecosystems: Maximizing non-profit partnerships alongside patient support networks.

"Commercializing a rare disease therapy requires a fundamental departure from mass-market pharma strategies, which is why we are so delighted to partner with DTC Perspectives for this inaugural event," said Olivier Chateau, Co-Founder and CEO of Health Union. "This joint venture reflects our shared, ongoing commitment to the rare disease community. By combining Health Union's deep community connections with DTC Perspectives' premier executive reach, we are taking the first step in a lasting partnership to help marketers reach and support these critical, underserved audiences."

"We are thrilled to join forces with Health Union for this milestone collaboration," added Bob Ehrlich, CEO of DTC Perspectives. "Bringing together our complementary strengths allows us to offer biopharma leaders an unprecedented, peer-to-peer environment. This summit is just the beginning of our joint efforts to provide marketers with novel opportunities to exchange proven approaches for AI targeting, non-specialist HCP engagement, and authentic advocacy alignment in the rare disease space."

The Future of the Partnership: Dedicated Workshop & Awards Ceremony in June 2027

The November summit in Boston represents only the first milestone in this collaborative effort. Building on the momentum of this inaugural gathering, Health Union and DTC Perspectives will expand their rare disease initiative with a dedicated Rare Disease Workshop and Awards Ceremony in June 2027, featured as an official extension of the annual DTC National Conference. This ongoing extension will serve as a premier stage to celebrate breakthroughs, honor pioneering marketers, and deepen industry-wide collaboration year after year. 

Attendance for the November 5 event is strictly capped to preserve the intimacy of executive peer exchange. Invited biopharma leaders can request registration details at https://go.dtcperspectives.com/rare-marketing-summit.

About Health Union

Health Union powers the first and largest community-based activation and data platform, transforming healthcare by providing unparalleled support, information, and validation for millions navigating complex health conditions and their care teams. With over 125 condition-specific online communities and 15 years of digital health leadership, Health Union's authentic engagements fuel the company's robust suite of endemic media, influencer marketing, market research, and data solutions, driving proven outcomes for patients, HCPs, and brands. Go to www.health-union.com to learn more.

About DTC Perspectives

DTC Perspectives, Inc. has been the leader in the direct-to-consumer marketing of pharmaceuticals and medical devices since 2001. Founded by Robert Ehrlich, the former VP Consumer Marketing for Parke-Davis, DTC Perspectives focuses on the emerging consumer desire for health information. Each year the DTC National Conference brings together marketers, their agencies, and media companies to discuss the latest in DTC Marketing. DTC Perspectives also consults, publishes studies, and represents the industry on important issues. Go to www.dtcperspectives.com to learn more.

SOURCE Health Union